One of the significant innovations in breast cancer prevention is the development of pill-based treatments designed to reduce the risk for high-risk women. These include medications like tamoxifen and anti-estrogen aromatase inhibitors, which have shown efficacy in lowering breast cancer rates, particularly among women with genetic predispositions or dense breast tissue.
Sylvester Comprehensive Cancer Center’s participation in the TAPUR trial has allowed for personalized treatments based on genetic mutations driving cancer growth. Precision medicine aims to treat breast cancer by tailoring drugs to the specific mutations in a patient’s tumor, improving outcomes and reducing side effects.
An innovative trial explores how aligning meal times and physical activity with circadian rhythms can reduce treatment-related fatigue in breast cancer patients. This approach is particularly promising for those undergoing intensive treatments like CDK4/6 inhibitors, offering better quality of life.
SLYMPHA, a relatively simple surgical technique, pioneered by Sylvester's team, significantly reduces the risk of lymphedema—a painful and persistent condition often caused by breast cancer surgeries and radiation. This procedure reconnects lymph channels, offering relief to thousands of patients.
To address lymphedema, Sylvester offers comprehensive care through its Lymphatic Center of Excellence. With an interdisciplinary team of specialists, the center develops personalized care plans, ensuring breast cancer survivors receive the best treatment options to manage lymphedema effectively.
These five advances represent just a fraction of the exciting progress in breast cancer care, offering hope for better prevention, treatment, and quality of life for patients.
From Ecomhao
Visit our site and see all other available articles!